This study analyzed data on 2121 patients with stage 3 to 5 ND-CKD, treated at U.S. and Brazilian nephrology clinics. A higher risk of all-cause mortality and physical inactivity were significantly ...
Minneapolis, MN - A retrospective analysis of the Valsartan Heart Failure Trial (Val-HeFT) has shown that in patients with moderate to severe HF, changes in hemoglobin (Hgb) levels over 12 months were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback